According to filings with the U.S. Securities and Exchange Commission, Kalogon is raising up to $7,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Kalogon
Kalogon is best known for pioneering smart seating solutions that reduce the stresses of sitting and improve seated health. Our patent-pending Advanced Pressure Management System (APMS) powers products with adaptive customizations, ambient adjustments, and personalized settings that enhance comfort and reduce fatigue for wheelchair users, pilots, and others who spend extended time seated. With four Medicare-coded products on the market, we prioritize user-centered design to ensure true market fit and lasting impact. By listening closely to the needs of wheelchair users, clinicians, and professionals across industries, Kalogon develops solutions that set a new benchmark for seated comfort and protection.

To learn more, visit https://www.kalogon.com/
LinkedIn: https://www.linkedin.com/company/kalogon/

Contact:
Tim Balz, Chief Executive Officer
https://www.linkedin.com/in/timbalz/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.